Hermetica Superfood Encyclopedia
The Short Answer
Sea cucumber glycolipids from Stichopus japonicus encompass cerebrosides and glycosphingolipids that are absorbed in vivo, converted to ceramides, and incorporated into cell membranes to modulate skin barrier integrity, lipid metabolism, and apoptotic signaling in tumor cells. Preclinical data demonstrate that related sea cucumber glycosides induce apoptosis in HL-60, MCF-7, and B16F10 cancer cell lines via caspase-3 upregulation and cell cycle arrest, with triterpene glycoside stichoposide D showing an IC50 of 0.26 ± 0.02 µM in NTERA-2 cells, though no human clinical trials have confirmed these effects.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary Keywordsea cucumber glycolipids benefits
Sea Cucumber Glycolipids — botanical close-up
Health Benefits
**Skin Barrier Enhancement**: Cerebrosides from S
japonicus are absorbed intact in animal models and metabolized into ceramides, which integrate into the stratum corneum to reinforce epidermal barrier function and reduce transepidermal water loss.
**Gut Microbiome Modulation**
In vivo absorption of cerebrosides elevates cecal short-chain fatty acid concentrations, suggesting a prebiotic-like effect that may support colonic epithelial health and microbial diversity.
**Antitumor Activity**
Glycosphingolipids and related glycosides from Apostichopus japonicus (a closely related species) induce sub-G1 and S-phase cell cycle arrest and caspase-3-mediated apoptosis in human cancer cell lines including HL-60 leukemia and MCF-7 breast cancer cells.
**Immunomodulation**
Sea cucumber-derived glycolipid fractions modulate innate immune responses by influencing macrophage activation pathways and cytokine secretion profiles, as observed in preclinical models of inflammation.
**Lipid Metabolism Regulation**
Glycosphingolipids interact with lipid raft microdomains in cellular membranes, influencing cholesterol trafficking, sphingolipid signaling cascades, and downstream regulation of lipid homeostasis enzymes.
**Anti-Inflammatory Effects**: Bioactive lipid fractions from S
japonicus suppress pro-inflammatory mediators including NF-κB pathway activation and prostaglandin synthesis in murine inflammation models, consistent with the organism's traditional wound-healing use.
**Drug Delivery Potential**
Liposomes formulated from sea cucumber glycolipids demonstrate particle sizes of approximately 169 nm and confirmed safety at 0.1 mg/mL, providing a biocompatible nanocarrier scaffold for targeted pharmaceutical applications.
Origin & History
Natural habitat
Stichopus japonicus, the Japanese sea cucumber, inhabits the coastal waters of Japan, China, South Korea, and Russia, thriving in rocky subtidal zones and sandy seafloors at depths of 0–20 meters. It is extensively harvested and aquacultured in East Asia, particularly in Chinese coastal provinces such as Shandong and Liaoning, where it has been commercially farmed for centuries. The body wall of this echinoderm is the primary source of glycolipids, which are concentrated in its tegument and visceral tissues and extracted via lipid fractionation techniques from dried or fresh specimens.
“Sea cucumbers, including S. japonicus, have occupied a significant place in Chinese, Japanese, and Korean traditional medicine for over 1,000 years, referenced in the Compendium of Materia Medica (Bencao Gangmu, 16th century CE) by Li Shizhen as a tonic for kidney deficiency, impotence, wound healing, and general vitality. In Japan, dried S. japonicus (known as 'iriko' or 'konowata' when processed as visceral paste) has been a luxury culinary ingredient since the Edo period, consumed for purported longevity and anti-inflammatory properties and traded as a premium commodity throughout maritime East Asia. Traditional preparation methods in China involve boiling, drying, and rehydrating the body wall to concentrate bioactive constituents including glycosphingolipids, collagen, and chondroitin sulfate, a process that partially preserves lipid fractions while destroying more heat-labile peptides. The cultural valorization of sea cucumber as a prestige health food in Chinese banquet cuisine (bai-yu or sea cucumber feast dishes) reflects centuries of empirical observation linking consumption with improved joint function, skin health, and post-illness recovery.”Traditional Medicine
Scientific Research
The evidence base for S. japonicus glycolipids consists exclusively of in vitro cell culture experiments and rodent in vivo studies, with no registered or completed human clinical trials identified in available literature as of 2024. In vivo animal studies have confirmed oral bioavailability of cerebrosides and their conversion to ceramides, with measurable increases in cecal short-chain fatty acids, but these studies lack dose-response quantification specific to isolated glycolipid fractions. Antitumor activity has been documented in multiple cell line panels including HL-60, MCF-7, Hep3B, and B16F10, with IC50 values established for related triterpene glycosides (e.g., stichoposide D at 0.26 ± 0.02 µM in NTERA-2 cells), though these compounds are structurally distinct from polar glycolipids and extrapolation requires caution. The overall evidence tier is preliminary, reflecting a consistent but exclusively preclinical dataset that warrants escalation to pharmacokinetic human studies and controlled trials before any therapeutic claims can be substantiated.
Preparation & Dosage
Traditional preparation
**Dried Body Wall Powder**
3–10 g dried body wall per day in East Asian culinary-medicinal contexts, providing a mixture of glycolipids, collagen, and polysaccharides
Traditional preparation; no clinically validated dose established; typically consumed as .
**Lipid Extract (Standardized Fraction)**
Experimental research preparations use organic solvent fractionation (chloroform:methanol); no commercial standardization percentage for glycolipid content is established.
**Liposomal Formulation**
1 mg/mL confirmed safe in cell-based toxicity assays; particle size approximately 169 nm; not yet in clinical use
Preclinical drug delivery studies utilize glycolipid-based liposomes at 0..
**Tonic Oral Liquid (Traditional)**
Aqueous extraction used in Chinese traditional medicine; triterpene glycoside content varies by processing method, with pickled forms retaining higher glycoside concentrations than heat-processed tonics.
**Timing and Standardization Note**
No clinical evidence supports specific dosing timing; bioavailability of cerebrosides is confirmed in animal models but human-equivalent doses have not been determined; consumers should be aware that no regulatory body has established a tolerable upper intake level for isolated sea cucumber glycolipids.
Nutritional Profile
The dried body wall of S. japonicus is approximately 82% protein by dry weight, rich in collagen-type I fibers and containing notable concentrations of glycosaminoglycans (chondroitin sulfate, heparan sulfate). Total lipid content in sea cucumbers ranges from 0.24–0.83% of dry weight across species, with the glycolipid subfraction (cerebrosides, glycosphingolipids, gangliosides) constituting a minor but bioactive proportion of the lipid pool; species-specific quantification for S. japonicus glycolipids is not established in published literature. Mineral content includes calcium, magnesium, and zinc in significant concentrations, and the organism is a dietary source of omega-3 polyunsaturated fatty acids (EPA and DHA), which are esterified within its phospholipid and glycolipid fractions. Bioavailability of glycolipid components is enhanced by co-ingestion with dietary fats given their lipophilic nature, and the ceramide metabolites generated post-digestion show confirmed absorption in rodent gastrointestinal models, though human bioavailability data are absent.
How It Works
Mechanism of Action
Cerebrosides derived from S. japonicus undergo hydrolysis post-absorption in the small intestine, releasing sphingosine and fatty acid moieties that are re-acylated into ceramide species; these ceramides integrate into lipid bilayers of epithelial cells, reinforcing tight junction integrity and modulating sphingosine-1-phosphate (S1P) receptor signaling involved in cell survival and migration. At the oncological level, glycosphingolipids and triterpene glycosides from closely related species activate intrinsic apoptotic cascades by upregulating caspase-3 expression, triggering cytochrome c release from mitochondria, and inhibiting DNA synthesis through interference with topoisomerase II activity, collectively arresting cell cycles at sub-G1 and S phases. Short-chain fatty acids generated through cecal fermentation of glycolipid-derived substrates activate G-protein coupled receptors GPR41 and GPR43 on colonocytes and immune cells, downregulating histone deacetylase activity and suppressing NF-κB-mediated inflammatory transcription. Additionally, glycosphingolipids modulate lipid raft organization within plasma membranes, altering receptor clustering for growth factor receptors such as EGFR and insulin receptors, which influences downstream PI3K/Akt and MAPK signaling relevant to both metabolic and proliferative regulation.
Clinical Evidence
No human clinical trials have investigated isolated glycolipids from S. japonicus for any health endpoint, representing a critical gap in translational research. Available preclinical outcomes include in vivo ceramide incorporation in rodent skin models, cecal short-chain fatty acid elevation, and in vitro caspase-3 activation and cell cycle arrest in multiple human cancer cell lines. Effect sizes documented in vitro (e.g., stichoposide D IC50 of 0.26 µM; 15% sub-G1 arrest) are pharmacologically meaningful but cannot be reliably extrapolated to human therapeutic dosing without pharmacokinetic bridging studies. Confidence in clinical applicability is low given the complete absence of controlled human data, and all proposed benefits remain speculative pending properly designed Phase I/II clinical investigations.
Safety & Interactions
Sea cucumber glycolipid preparations exhibit low toxicity in preclinical models, with liposomal formulations confirmed safe at 0.1 mg/mL in cytotoxicity assays, and whole sea cucumber extracts showing no significant adverse effects in rodent studies at tested doses; however, no formal maximum tolerable dose or NOAEL has been established for isolated S. japonicus glycolipids in any species. Individuals with shellfish or marine organism allergies should exercise caution, as glycoproteins and lipid-associated antigens in sea cucumber products may trigger cross-reactive hypersensitivity responses. No specific drug interactions have been documented for S. japonicus glycolipids in clinical or pharmacological literature, though theoretical interactions with anticoagulants (due to chondroitin sulfate co-extraction in whole-body-wall preparations) and immunosuppressants (given immunomodulatory activity) warrant monitoring in vulnerable populations. Pregnancy and lactation safety have not been evaluated in any study; consumption of whole sea cucumber as a food appears to be traditionally accepted in Asian populations during pregnancy, but isolated glycolipid concentrates should be avoided until human safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Stichopus japonicusJapanese sea cucumber glycolipidssea cucumber cerebrosides海参糖脂 (hǎishēn tánglǐ)iriko lipid extractApostichopus japonicus glycolipids
Frequently Asked Questions
What are sea cucumber glycolipids and what do they do?
Sea cucumber glycolipids from Stichopus japonicus are lipid-carbohydrate conjugates, primarily cerebrosides and glycosphingolipids, found in the body wall of this marine echinoderm. After oral ingestion, cerebrosides are hydrolyzed and reassembled into ceramides that strengthen the skin's epidermal barrier and elevate short-chain fatty acid production in the gut; in preclinical cancer studies, related glycosides induce caspase-3-mediated apoptosis in multiple tumor cell lines.
Is there clinical trial evidence for sea cucumber glycolipids?
As of 2024, no human clinical trials have been conducted specifically on isolated glycolipids from S. japonicus for any health condition. Available evidence is limited to in vitro cell studies demonstrating antitumor activity and rodent in vivo studies confirming cerebroside absorption and ceramide formation; all proposed therapeutic benefits remain at the preclinical stage and should not be interpreted as established medical claims.
How are sea cucumber glycolipids taken as a supplement?
No clinically validated supplemental dose exists for isolated sea cucumber glycolipids. Traditional consumption involves 3–10 g of dried S. japonicus body wall daily in East Asian culinary-medicinal contexts, providing a complex mixture of glycolipids alongside collagen, chondroitin sulfate, and minerals. Experimental liposomal formulations (particle size ~169 nm) have been studied as drug delivery systems at 0.1 mg/mL in preclinical settings, but these are not commercially available.
Are sea cucumber glycolipids safe to consume?
Whole sea cucumber consumption has a long history of safety in East Asian populations, and preclinical studies of extracts and liposomal preparations show low toxicity at tested concentrations (safe at 0.1 mg/mL in cell-based assays). No formal human safety data exist for isolated glycolipid concentrates, and individuals with marine organism allergies should avoid these products due to potential cross-reactive hypersensitivity. Pregnant or breastfeeding individuals should not use concentrated extracts until safety is established.
How do sea cucumber glycolipids differ from sea cucumber saponins?
Sea cucumber glycolipids (cerebrosides, glycosphingolipids) and saponins (triterpene glycosides such as holothurin and stichoposide) are structurally distinct compound classes despite both containing glycan moieties. Glycolipids are lipid-based with fatty acid and sphingosine backbones, and their primary documented activities include ceramide formation, skin barrier support, and membrane modulation, whereas triterpene glycosides are terpenoid in nature and have been more extensively studied for cytotoxic and antifungal effects with quantified IC50 values as low as 0.26 µM. Both classes co-occur in sea cucumber extracts, and many commercial products contain mixtures of both.
How do sea cucumber glycolipids from Stichopus japonicus support skin barrier function?
Sea cucumber glycolipids contain cerebrosides that are absorbed intact and metabolized into ceramides, which integrate directly into the stratum corneum layer of the skin. This integration reinforces the epidermal barrier and reduces transepidermal water loss, helping to maintain skin hydration and strengthen the skin's natural protective barrier.
Can sea cucumber glycolipids act as a prebiotic and support gut health?
Research indicates that absorbed cerebrosides from Stichopus japonicus elevate short-chain fatty acid concentrations in the cecum, suggesting a prebiotic-like mechanism that may support beneficial gut microbiota. This metabolic activity indicates the ingredient may influence microbial composition and fermentation patterns in the digestive tract.
What makes cerebrosides from Stichopus japonicus different from other skin-supporting glycolipids?
Cerebrosides from Stichopus japonicus are uniquely absorbed in their intact form in animal models, allowing them to be metabolized into ceramides that directly integrate into skin structure. This intact absorption pathway and subsequent ceramide conversion distinguishes them from other glycolipids that may be broken down before reaching target tissues.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w glycolipids-stichopus-japonicus curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
